Dr Nemenoff and Colin Barton post Summit interview

ALK Positive awarded a $200,000 grant in 2018 to Dr Raphael Nemenoff to research new ways to better treat ALK- positive lung cancer. Dr Nemenoff is a leading researcher at the University of Colorado, working with Dr Ross Camidge, a world-leading ALK lung cancer expert and thoracic oncologist. Dr Colin Barton was diagnosed with ALK-positive lung cancer in 2016, and is Chair of the ALK Positive Medical Committee. Here, on August 14, 2020, Colin interviews Dr Nemenoff. Dr. Nemenoff discusses his research and the human immune system and specifically the complement system. WATCH VIDEO

ALK Positive Inc.

Authors: Dr. Nemenoff

VideoKirk SmithAugust 20, 2020ALK summit 2020